Search results for "Receptor"

showing 10 items of 6990 documents

Identificación de TCRs reactivos contra neoantígenos tumorales en muestras de pacientes con CPNM mediante secuenciación de nueva generación. Implicac…

2021

A pesar del éxito de la inmunoterapia con los bloqueantes de los puntos del control inmune (ICBs) en el cáncer de pulmón, el porcentaje de pacientes que se beneficia de este tipo de tratamiento sigue siendo inferior al 30%, por lo que aún es necesario el desarrollo de nuevos posibles biomarcadores para una mejor selección de los pacientes. El objetivo principal del presente trabajo de tesis doctoral es caracterizar el repertorio de la cadena beta del receptor de células T (TCR-β) en sangre periférica y correlacionar con las variables demográficas, clínico-patológicas, predictivas y pronósticas en una cohorte de pacientes con cáncer de pulmón no microcítico (CPNM) en estadios avanzados trata…

tcr-βbiopsia líquidacadena beta del receptor de células tUNESCO::CIENCIAS MÉDICASbloqueantes de puntos de control inmunecáncer de pulmón no microcíticobiomarcadorcdr3:CIENCIAS MÉDICAS [UNESCO]inmunoterapiasecuenciación de nueva generación
researchProduct

Estudio de los mecanismos responsables del efecto protrombótico de Abacavir

2021

La terapia antirretroviral combinada es la que se utiliza para el tratamiento del virus de la inmunodeficiencia humana (VIH) y ha permitido que el síndrome de inmunodeficiencia adquirida (SIDA) haya pasado de ser una enfermedad mortal a crónica. Sin embargo, su uso se ha asociado con la aparición de diversos efectos adversos, entre ellos las enfermedades cardiovasculares. Debido a que los fármacos antirretrovirales se pautan de manera combinada, es difícil establecer la implicación de cada uno de los fármacos en estos efectos adversos. Abacavir (ABC) —inhibidor de la transcriptasa inversa análogo de nucleósido, concretamente de la guanina (purina endógena)— ha sido relacionado con un mayor …

terapia antirretroviraltrombosisabacavir:CIENCIAS MÉDICAS ::Farmacología [UNESCO]plaquetatoxicidad cardiovascularleucocitoUNESCO::CIENCIAS MÉDICAS ::Farmacologíareceptores purinérgicos
researchProduct

Effect of ligand-binding on protein function

2014

tietokonesimulointifilamiinitliganditsitoutuminenionotrooppiset glutamaattireseptoritfilaminpeptidiliganditmolecular dynamicsionotropic glutamate receptorlääkesuunnitteluFLNaiGluRlaskennallinen tiedelaskennalliset menetelmätmolekyylidynamiikkaTCPTPsimulointiproteiinitbinding free energyT-cell protein tyrosine phosphatase
researchProduct

Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression

2021

Microbiota is a complex ecosystem of active microorganisms resident in the body of mammals. Although the majority of these microorganisms resides at the distal gastrointestinal tract, high-throughput DNA sequencing technology have made possible to understand that several other tissues of the human body host their own microbiota, even those once considered sterile, such as lung tissue. These bacterial communities have important functions in maintaining a healthy body state and the host immune system has evolved multiple mechanisms by which maintaining a symbiotic relationship with the microbiota. The maintenance of this dialogue allows the induction of protective responses to pathogens and r…

toleranceQH301-705.5toll-like receptor (TLR)CancerReviewCell BiologydysbiosisBiologymedicine.diseaseCommensalismCell and Developmental BiologyImmune systemCancer cellImmunologymedicinemicrobiotacancerMicrobiomeBiology (General)ReceptorPathogenDysbiosisDevelopmental BiologyFrontiers in Cell and Developmental Biology
researchProduct

Synthesis and biological evaluation of the antioxidant properties of new analogues of natural products with piperidine based structure and evaluation…

triazoleBetalainsOrganic synthesisIndicaxanthinsigma receptorKORsSettore CHIM/08 - Chimica Farmaceutica
researchProduct

Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments

2021

Muscle wasting, i.e., cachexia, frequently occurs in cancer and associates with poor prognosis and increased morbidity and mortality. Anticancer treatments have also been shown to contribute to sustainment or exacerbation of cachexia, thus affecting quality of life and overall survival in cancer patients. Pre-clinical studies have shown that blocking activin receptor type 2 (ACVR2) or its ligands and their downstream signaling can preserve muscle mass in rodents bearing experimental cancers, as well as in chemotherapy-treated animals. In tumor-bearing mice, the prevention of skeletal and respiratory muscle wasting was also associated with improved survival. However, the definitive proof tha…

tumorCachexiaActivin ReceptorsActivin Receptors Type IIMyostatinReviewchemotherapymulti-organType IIsurvivalCachexiaNeoplasmsmedicineRespiratory muscleHumansActivins; Cancer cachexia; Chemotherapy; Mortality; Multi-organ; Muscle wasting; Myostatin; Survival; Tumor; Activin Receptors Type II; Cachexia; Humans; Neoplasms; Signal Transduction; Survival Analysislcsh:QH301-705.5Wastingsoluviestintäbiologysyöpähoidotbusiness.industryactivinsCancerSkeletal musclemuscle wastingGeneral MedicineActivin receptormedicine.diseaseSurvival AnalysismortalityBlockademedicine.anatomical_structurelcsh:Biology (General)myostatinCancer researchbiology.proteinproteiinitmedicine.symptombusinesshenkiinjääminenlihassurkastumasairaudetSignal Transductioncancer cachexia
researchProduct

Mast cells as protectors of health.

2019

Mast cells (MCs), which are well known for their effector functions in T(H)2-skewed allergic and also autoimmune inflammation, have become increasingly acknowledged for their role in protection of health. It is now clear that they are also key modulators of immune responses at interface organs, such as the skin or gut. MCs can prime tissues for adequate inflammatory responses and cooperate with dendritic cells in T-cell activation. They also regulate harmful immune responses in trauma and help to successfully orchestrate pregnancy. This review focuses on the beneficial effects of MCs on tissue homeostasis and elimination of toxins or venoms. MCs can enhance pathogen clearance in many bacter…

tumorImmunologyvenomTryptaseMast cell; innate immunity; infection; mast cell protease; tumor; pregnancy; venom; toxin; central nervous system traumaInfectionsCell DegranulationMast Cell ; Innate Immunity ; Infection ; Mast Cell Protease ; Tumor ; Pregnancy ; Venom ; Toxin ; Central Nervous System TraumaImmune systemCathelicidinsPregnancymedicineImmunology and AllergyAnimalsHomeostasisHumansEmbryo ImplantationMast CellsCNS traumatoxininnate immunityTissue homeostasismast cell proteaseToll-like receptorTumor microenvironmentInnate immune systembiologybusiness.industryDegranulationMast cellhumanitiesImmunity InnateToll-Like Receptor 2infectionddc:medicine.anatomical_structureImmunologybiology.proteinFemalepregnancybusinessmast cell
researchProduct

Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions?

2021

The metabolic changes that occur in tumor microenvironment (TME) can influence not only the biological activity of tumor cells, which become more aggressive and auto sustained, but also the immune response against tumor cells, either producing ineffective responses or polarizing the response toward protumor activity. γδ T cells are a subset of T cells characterized by a plasticity that confers them the ability to differentiate towards different cell subsets according to the microenvironment conditions. On this basis, we here review the more recent studies focused on altered tumor metabolism and γδ T cells, considering their already known antitumor role and the possibility of manipulating th…

tumoral metabolismQH301-705.5T-LymphocytesPopulationReviewMajor histocompatibility complexγδ T cellsImmune systemAntigens NeoplasmIn vivomedicineAnimalsHumanstumor microenvironmentBiology (General)educationtumoral metabolism; ?? T cells; tumor microenvironmentClinical Trials as Topiceducation.field_of_studyTumor microenvironmentbiologyReceptors Antigen T-Cell gamma-deltaBiological activityGeneral MedicineHypoxia (medical)Lipid MetabolismIn vitroCell biologybiology.proteinmedicine.symptom
researchProduct

Could PD-1/PDL1 immune checkpoints be linked to HLA signature?

2019

The outstanding clinical expansion of monoclonal antibodies (mAbs) to programmed cell death receptor-1 (PD-1) (nivolumab and pembrolizumab) and PD-1 ligand-1 (PDL-1) (atezolizumab, avelumab and durvalumab) has received an increasing level of interest regarding immunotherapy and multidrug combinations, for the treatment of a number of common human malignancies. Some patients treated with these agents receive remarkable benefits in term of quality of life, progression-free (PFS) and overall survival (OS). However, a significant percentage of these patients experience immune-related adverse events (irAEs), while others present with an ultra-rapid disease progression, defined as hyperprogressio…

vDrug-Related Side Effects and Adverse ReactionsProgrammed Cell Death 1 ReceptorImmunologyAntibodies Monoclon alHuman leukocyte antigenB7-H1 AntigenImmune systemHLA AntigensirAENeoplasmsHumansImmunology and AllergyMedicinePD-1/PDL-1-blockadebusiness.industryAntibodies MonoclonalBiomarkerProgrammed Cell Death 1 ReceptorSignature (logic)HaplotypesOncologyImmunologyoutcomeImmunotherapyHLA alleleDrug-Related Side Effects and Adverse ReactionbusinessBiomarkersB7-H1 AntigenImmunotherapy
researchProduct

Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms i…

2014

Single nucleotide polymorphisms (SNPs) in genes involved in the activation or regulation of innate and adaptive immune responses may modulate the susceptibility to and the natural history of certain chronic viral infections. The current study aimed to investigate whether donor and recipient SNPs in the chemokine receptor 5 (rs1800023), monocyte chemoattractant protein 1 (rs13900), interleukin-10 (rs1878672), and Toll-like receptor 9 (rs352140) genes would exert any influence on the rate of incidence and features of CMV DNAemia in the allogeneic stem cell transplantation setting. This was a retrospective observational multicenter study. The cohort consisted of 102 non-consecutive allogeneic …

virus diseasesTLR9Single-nucleotide polymorphismBiologyVirologySNP genotypingTransplantationInterleukin 10Chemokine receptorInfectious DiseasesImmune systemVirologyGenotypeImmunologyJournal of Medical Virology
researchProduct